2021 Varian Users Meeting | Varian

Towards MR-only Treatment Planning in Brachytherapy

As the value of imaging for treatment planning continues to grow, learn how Brigham and Women’s Hospital is capitalizing on MR images in the treatment position.

• Evangelia (Allia) Kaza, PhD, Instructor in Radiation Oncology, Brigham and Women’s Hospital

UT Southwestern Clinical Implementation of Ethos

Hear the physician perspective on a new treatment approach UT Southwestern is pioneering using Ethos therapy, PULSAR, and their experience getting started.

• Kiran Kumar, MD, MBA, Assistant Professor of Radiation Oncology, UT Southwestern Medical Center

Host: Cecile Mohr, VP, Global Product Marketing, Varian, a Siemens Healthineers Company

Watch the replay

Expanding Access to Proton Therapy

Learn how a compact single-room center can drive efficiency and expand access to proton therapy.

• James W. Snider, III, MD, Associate Medical Director of Proton Therapy, University of Alabama at Birmingham School of Medicine

Single-Institution Experience Implementing the Varian Multi-channel Applicator

Join Christopher Tien as he shares Yale’s commissioning, clinical experience, insights and resultant dosimetric impacts using the Varian Multichannel Applicator for HDR GYN brachytherapy.

• Christopher J. Tien, PhD, DABR, Assistant Professor of Therapeutic Radiology, Yale School of Medicine

Host: Jan Timmer, Senior Director, Proton Marketing, Varian, a Siemens Healthineers Company

Watch the replay

Value-based Care: Partnering to Provide Solutions for Customer Success

Are you looking for guidance on the upcoming Proposed Radiation Oncology Alternative Payment Model and the solutions to assist you with this transition? Join us for an update on the Proposed Radiation Oncology Alternative Payment Model and the Varian products that can help you.

• Fabian Marechal, MS, Chief Operating Officer, Department of Radiation Oncology and Proton Therapy, Penn Medicine - Perelman Center for Advanced Medicine
• Helen Phillips, Senior Product Marketing Manager, Varian, a Siemens Healthineers Company
• Stacy Stordahl, VP, Reimbursement and Market Access, Varian, a Siemens Healthineers Company
• Kathy Wall, Director, Enterprise Solutions, Varian, a Siemens Healthineers Company

Host: Christina Carrica Haley, VP, Government Affairs, Americas, Varian, a Siemens Healthineers Company

11:30-11:45: Our Path Forward: Shaping the Future of Oncology through Intelligent Cancer Care

You won’t want to miss this interactive session to discover how we are harnessing the power of Intelligent Cancer Care to provide a fully integrated, connected care pathways that address the entire patient journey.

• Chris Toth, Chief Executive Officer, Varian, a Siemens Healthineers Company

11:45-12:15: Smart Services in an Increasingly Remote and Ever-changing World

Hear how one clinic accelerated their service transformation, reduced downtime and contained costs during “the new normal.”

• David Good, MS DABR, Medical Physicist, Penn Highlands DuBois
• Steve Leonard, VP, Global Customer Service, Varian, a Siemens Healthineers Company
• Jim Miller, RT(T), CMD, Penn Highlands DuBois

12:15-12:45: Opportunities in Radiation Oncology – Panel Discussion

Join this panel discussion to learn the possibilities for providing world-class RT cancer care afforded through the Varian and Siemens combination.

• Dorin Comaniciu, PhD, SVP AI and Digital Innovation, Siemens Healthineers
• Daniel Low, PhD, FAAPM, FASTRO, Professor and Vice Chair of Medical Physics, Department of Radiation Oncology University of California – Los Angeles
• Ramesh Rengan, MD, PhD, FASTRO, Professor and Chair in the Department of Radiation Oncology, University of Washington
• Pat Kupelian, MD (Moderator), VP, Medical Affairs, Varian, a Siemens Healthineers Company

Host: John Kowal, President, Americas, Varian, a Siemens Healthineers Company

Phase II Trial of Daily Adaptive Hypofractionated Radiation Therapy plus Concurrent Chemotherapy for Muscle-invasive Bladder Cancer

Gain insight into the Innovation made possible by daily adaptation: Ethos and bladder cancer.

• Brian C. Baumann, MD, Washington University School of Medicine

FLASH: Translating Biology to Clinical Implementation

Hear the latest on how Varian is making FLASH* therapy a clinical reality.

• Agam Sharda, VP, FLASH Solutions, Varian, a Siemens Healthineers Company

Host: Lisa Levine, Sr. Director, Clinical Operations, Varian, a Siemens Healthineers Company

*FLASH therapy is under development and not available for commercial sale.